Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin

被引:94
|
作者
Reiter, RA
Knöbl, P
Varadi, K
Turecek, PL
机构
[1] Univ Vienna, Dept Med 1, A-1090 Vienna, Austria
[2] Univ Vienna, Dept Clin Pharmacol, A-1090 Vienna, Austria
[3] Baxter Bio Sci, Vienna, Austria
关键词
D O I
10.1182/blood-2002-03-0814
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand factor-cleaving protease (ADAMTS13) cleaves von Willebrand factor (VWF) and regulates its physiologic function. To investigate the relation between ADAMTS13 activity and VWF, we compared ADAMTS13 activity with the VWF-related parameters VWF antigen (VWF:Ag), VWF collagen-binding activity (VWF:CBA), VWF-propeptide, proVWF, and VWF multimeric composition in 10 healthy volunteers and 3 patients with type 1 von Willebrand disease before and after infusing 0.3 mug/kg desmopressin. The VWF-related parameters in the volunteers increased 60 minutes after start of infusion by 3.7-fold for VWF:Ag, 7.2-fold for propeptide, and 2.2-fold for VWF: CBA. Unusually large VWF multimers and traces of proVWF appeared. The ADAMTS13 activity decreased to about half the initial value. After 24 hours values returned to baseline. Patients with type 1 von Wille-brand disease showed similar results. We conclude that the inverse correlation between ADAMTS13 and VWF-related parameters suggests a consumption of ADAMTS13 after the desmopressin-induced release of higher multimers of VWF. (C) 2003 by The American Society of Hematology.
引用
收藏
页码:946 / 948
页数:3
相关论文
共 50 条
  • [21] Detection of von Willebrand factor-cleaving protease (ADAMTS-13) in human platelets
    Suzuki, M
    Murata, M
    Matsubara, Y
    Uchida, T
    Ishihara, H
    Shibano, T
    Ashida, S
    Soejima, K
    Okada, Y
    Ikeda, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 313 (01) : 212 - 216
  • [22] ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13
    Antoine, G
    Zimmermann, K
    Plaimauer, B
    Grillowitzer, M
    Studt, JD
    Lämmle, B
    Scheiflinger, F
    BRITISH JOURNAL OF HAEMATOLOGY, 2003, 120 (05) : 821 - 824
  • [23] Von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP
    Schneppenheim, R
    Budde, U
    Oyen, F
    Angerhaus, D
    Aumann, V
    Drewke, E
    Hassenpflug, W
    Häberle, J
    Kentouche, K
    Kohne, E
    Kurnik, K
    Mueller-Wiefel, D
    Obser, T
    Santer, R
    Sykora, KW
    BLOOD, 2003, 101 (05) : 1845 - 1850
  • [24] Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C
    Ekaney, Michael L.
    Bockmeyer, Clemens L.
    Sossdorf, Maik
    Reuken, Philipp A.
    Conradi, Florian
    Schuerholz, Tobias
    Blaess, Markus F.
    Friedman, Scott L.
    Loesche, Wolfgang
    Bauer, Michael
    Claus, Ralf A.
    MOLECULAR MEDICINE, 2015, 21 : 355 - 363
  • [25] Preserved Expression of mRNA Coding von Willebrand Factor-Cleaving Protease ADAMTS13 by Selenite and Activated Protein C
    Michael L. Ekaney
    Clemens L. Bockmeyer
    Maik Sossdorf
    Philipp A. Reuken
    Florian Conradi
    Tobias Schuerholz
    Markus F. Blaess
    Scott L. Friedman
    Wolfgang Lösche
    Michael Bauer
    Ralf A. Claus
    Molecular Medicine, 2015, 21 : 355 - 363
  • [26] Identification of strain-specific variants of mouse Adamts13 gene encoding von Willebrand factor-cleaving protease
    Banno, F
    Kaminaka, K
    Soejima, K
    Kokame, K
    Miyata, T
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (29) : 30896 - 30903
  • [27] Relation between von Willebrand factor-cleaving protease (ADAMTS13) activity and presenting features and outcomes of thrombotic thrombocytopenic purpura (TTP).
    Vesely, SK
    George, JN
    Lammle, B
    Studt, JD
    Alberio, L
    El-Harake, MA
    BLOOD, 2002, 100 (11) : 684A - 684A
  • [28] Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13)
    M. Böhm
    T. Vigh
    I. Scharrer
    Annals of Hematology, 2002, 81 : 430 - 435
  • [29] Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13)
    Böhm, M
    Vigh, T
    Scharrer, I
    ANNALS OF HEMATOLOGY, 2002, 81 (08) : 430 - 435
  • [30] Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia
    Molvarec, Attila
    Rigo, Janos, Jr.
    Boze, Tamas
    Derzsy, Zoltan
    Cervenak, Laszlo
    Mako, Veronika
    Gombos, Timea
    Udvardy, Miklos Laszlo
    Harsfalvi, Jolan
    Prohaszka, Zoltan
    THROMBOSIS AND HAEMOSTASIS, 2009, 101 (02) : 305 - 311